世界の抗核抗体（ANA）検査市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Anti-nuclear Antibody (ANA) Testing Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A13976 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、抗核抗体（ANA）検査のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。抗核抗体（ANA）検査の種類別市場規模（間接蛍光抗体法、酵素免疫測定法（ELISA）、その他）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・抗核抗体（ANA）検査の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Abcam、Antibodies、Bio-Rad Laboratories、Alere、Erba Diagnostics、MBL International、Merck、Indur Services、Trinity Biotech、Thermo Fisher Scientific、Zeus Scientific ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：間接蛍光抗体法、酵素免疫測定法（ELISA）、その他 ・用途別分析2016年-2026年：病院、クリニック、その他 ・抗核抗体（ANA）検査の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・抗核抗体（ANA）検査のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・抗核抗体（ANA）検査のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・抗核抗体（ANA）検査の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・抗核抗体（ANA）検査の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Anti-nuclear Antibody (ANA) Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Anti-nuclear Antibody (ANA) Testing size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Anti-nuclear Antibody (ANA) Testing market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Anti-nuclear Antibody (ANA) Testing market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Indirect Immunofluorescence
Enzyme-linked Immunosorbent Assay (ELISA)
Other

Market segment by Application, can be divided into
Hospital
Clinic
Other

Market segment by players, this report covers
Abcam
Antibodies
Bio-Rad Laboratories
Alere
Erba Diagnostics
MBL International
Merck
Indur Services
Trinity Biotech
Thermo Fisher Scientific
Zeus Scientific

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Anti-nuclear Antibody (ANA) Testing
1.2 Classification of Anti-nuclear Antibody (ANA) Testing by Type
1.2.1 Overview: Global Anti-nuclear Antibody (ANA) Testing Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Anti-nuclear Antibody (ANA) Testing Revenue Market Share by Type in 2020
1.2.3 Indirect Immunofluorescence
1.2.4 Enzyme-linked Immunosorbent Assay (ELISA)
1.2.5 Other
1.3 Global Anti-nuclear Antibody (ANA) Testing Market by Application
1.3.1 Overview: Global Anti-nuclear Antibody (ANA) Testing Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Anti-nuclear Antibody (ANA) Testing Market Size & Forecast
1.5 Global Anti-nuclear Antibody (ANA) Testing Market Size and Forecast by Region
1.5.1 Global Anti-nuclear Antibody (ANA) Testing Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Anti-nuclear Antibody (ANA) Testing Market Size by Region, (2016-2021)
1.5.3 North America Anti-nuclear Antibody (ANA) Testing Market Size and Prospect (2016-2026)
1.5.4 Europe Anti-nuclear Antibody (ANA) Testing Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size and Prospect (2016-2026)
1.5.6 South America Anti-nuclear Antibody (ANA) Testing Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Anti-nuclear Antibody (ANA) Testing Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Anti-nuclear Antibody (ANA) Testing Market Drivers
1.6.2 Anti-nuclear Antibody (ANA) Testing Market Restraints
1.6.3 Anti-nuclear Antibody (ANA) Testing Trends Analysis
2 Company Profiles
2.1 Abcam
2.1.1 Abcam Details
2.1.2 Abcam Major Business
2.1.3 Abcam Anti-nuclear Antibody (ANA) Testing Product and Solutions
2.1.4 Abcam Anti-nuclear Antibody (ANA) Testing Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Abcam Recent Developments and Future Plans
2.2 Antibodies
2.2.1 Antibodies Details
2.2.2 Antibodies Major Business
2.2.3 Antibodies Anti-nuclear Antibody (ANA) Testing Product and Solutions
2.2.4 Antibodies Anti-nuclear Antibody (ANA) Testing Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Antibodies Recent Developments and Future Plans
2.3 Bio-Rad Laboratories
2.3.1 Bio-Rad Laboratories Details
2.3.2 Bio-Rad Laboratories Major Business
2.3.3 Bio-Rad Laboratories Anti-nuclear Antibody (ANA) Testing Product and Solutions
2.3.4 Bio-Rad Laboratories Anti-nuclear Antibody (ANA) Testing Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.4 Alere
2.4.1 Alere Details
2.4.2 Alere Major Business
2.4.3 Alere Anti-nuclear Antibody (ANA) Testing Product and Solutions
2.4.4 Alere Anti-nuclear Antibody (ANA) Testing Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Alere Recent Developments and Future Plans
2.5 Erba Diagnostics
2.5.1 Erba Diagnostics Details
2.5.2 Erba Diagnostics Major Business
2.5.3 Erba Diagnostics Anti-nuclear Antibody (ANA) Testing Product and Solutions
2.5.4 Erba Diagnostics Anti-nuclear Antibody (ANA) Testing Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Erba Diagnostics Recent Developments and Future Plans
2.6 MBL International
2.6.1 MBL International Details
2.6.2 MBL International Major Business
2.6.3 MBL International Anti-nuclear Antibody (ANA) Testing Product and Solutions
2.6.4 MBL International Anti-nuclear Antibody (ANA) Testing Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 MBL International Recent Developments and Future Plans
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business
2.7.3 Merck Anti-nuclear Antibody (ANA) Testing Product and Solutions
2.7.4 Merck Anti-nuclear Antibody (ANA) Testing Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Merck Recent Developments and Future Plans
2.8 Indur Services
2.8.1 Indur Services Details
2.8.2 Indur Services Major Business
2.8.3 Indur Services Anti-nuclear Antibody (ANA) Testing Product and Solutions
2.8.4 Indur Services Anti-nuclear Antibody (ANA) Testing Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Indur Services Recent Developments and Future Plans
2.9 Trinity Biotech
2.9.1 Trinity Biotech Details
2.9.2 Trinity Biotech Major Business
2.9.3 Trinity Biotech Anti-nuclear Antibody (ANA) Testing Product and Solutions
2.9.4 Trinity Biotech Anti-nuclear Antibody (ANA) Testing Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Trinity Biotech Recent Developments and Future Plans
2.10 Thermo Fisher Scientific
2.10.1 Thermo Fisher Scientific Details
2.10.2 Thermo Fisher Scientific Major Business
2.10.3 Thermo Fisher Scientific Anti-nuclear Antibody (ANA) Testing Product and Solutions
2.10.4 Thermo Fisher Scientific Anti-nuclear Antibody (ANA) Testing Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.11 Zeus Scientific
2.11.1 Zeus Scientific Details
2.11.2 Zeus Scientific Major Business
2.11.3 Zeus Scientific Anti-nuclear Antibody (ANA) Testing Product and Solutions
2.11.4 Zeus Scientific Anti-nuclear Antibody (ANA) Testing Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Zeus Scientific Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Anti-nuclear Antibody (ANA) Testing Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Anti-nuclear Antibody (ANA) Testing Players Market Share
3.2.2 Top 10 Anti-nuclear Antibody (ANA) Testing Players Market Share
3.2.3 Market Competition Trend
3.3 Anti-nuclear Antibody (ANA) Testing Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Anti-nuclear Antibody (ANA) Testing Revenue and Market Share by Type (2016-2021)
4.2 Global Anti-nuclear Antibody (ANA) Testing Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Anti-nuclear Antibody (ANA) Testing Revenue Market Share by Application (2016-2021)
5.2 Anti-nuclear Antibody (ANA) Testing Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Anti-nuclear Antibody (ANA) Testing Revenue by Type (2016-2026)
6.2 North America Anti-nuclear Antibody (ANA) Testing Revenue by Application (2016-2026)
6.3 North America Anti-nuclear Antibody (ANA) Testing Market Size by Country
6.3.1 North America Anti-nuclear Antibody (ANA) Testing Revenue by Country (2016-2026)
6.3.2 United States Anti-nuclear Antibody (ANA) Testing Market Size and Forecast (2016-2026)
6.3.3 Canada Anti-nuclear Antibody (ANA) Testing Market Size and Forecast (2016-2026)
6.3.4 Mexico Anti-nuclear Antibody (ANA) Testing Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Anti-nuclear Antibody (ANA) Testing Revenue by Type (2016-2026)
7.2 Europe Anti-nuclear Antibody (ANA) Testing Revenue by Application (2016-2026)
7.3 Europe Anti-nuclear Antibody (ANA) Testing Market Size by Country
7.3.1 Europe Anti-nuclear Antibody (ANA) Testing Revenue by Country (2016-2026)
7.3.2 Germany Anti-nuclear Antibody (ANA) Testing Market Size and Forecast (2016-2026)
7.3.3 France Anti-nuclear Antibody (ANA) Testing Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Anti-nuclear Antibody (ANA) Testing Market Size and Forecast (2016-2026)
7.3.5 Russia Anti-nuclear Antibody (ANA) Testing Market Size and Forecast (2016-2026)
7.3.6 Italy Anti-nuclear Antibody (ANA) Testing Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Revenue by Type (2016-2026)
8.2 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Revenue by Application (2016-2026)
8.3 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Region
8.3.1 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Revenue by Region (2016-2026)
8.3.2 China Anti-nuclear Antibody (ANA) Testing Market Size and Forecast (2016-2026)
8.3.3 Japan Anti-nuclear Antibody (ANA) Testing Market Size and Forecast (2016-2026)
8.3.4 South Korea Anti-nuclear Antibody (ANA) Testing Market Size and Forecast (2016-2026)
8.3.5 India Anti-nuclear Antibody (ANA) Testing Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Anti-nuclear Antibody (ANA) Testing Market Size and Forecast (2016-2026)
8.3.7 Australia Anti-nuclear Antibody (ANA) Testing Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Anti-nuclear Antibody (ANA) Testing Revenue by Type (2016-2026)
9.2 South America Anti-nuclear Antibody (ANA) Testing Revenue by Application (2016-2026)
9.3 South America Anti-nuclear Antibody (ANA) Testing Market Size by Country
9.3.1 South America Anti-nuclear Antibody (ANA) Testing Revenue by Country (2016-2026)
9.3.2 Brazil Anti-nuclear Antibody (ANA) Testing Market Size and Forecast (2016-2026)
9.3.3 Argentina Anti-nuclear Antibody (ANA) Testing Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Revenue by Type (2016-2026)
10.2 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Revenue by Application (2016-2026)
10.3 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Country
10.3.1 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Revenue by Country (2016-2026)
10.3.2 Turkey Anti-nuclear Antibody (ANA) Testing Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Anti-nuclear Antibody (ANA) Testing Market Size and Forecast (2016-2026)
10.3.4 UAE Anti-nuclear Antibody (ANA) Testing Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Anti-nuclear Antibody (ANA) Testing Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Anti-nuclear Antibody (ANA) Testing Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Anti-nuclear Antibody (ANA) Testing Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Anti-nuclear Antibody (ANA) Testing Revenue (USD Million) by Region (2016-2021)
Table 5. Global Anti-nuclear Antibody (ANA) Testing Revenue Market Share by Region (2021-2026)
Table 6. Abcam Corporate Information, Head Office, and Major Competitors
Table 7. Abcam Major Business
Table 8. Abcam Anti-nuclear Antibody (ANA) Testing Product and Solutions
Table 9. Abcam Anti-nuclear Antibody (ANA) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Antibodies Corporate Information, Head Office, and Major Competitors
Table 11. Antibodies Major Business
Table 12. Antibodies Anti-nuclear Antibody (ANA) Testing Product and Solutions
Table 13. Antibodies Anti-nuclear Antibody (ANA) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors
Table 15. Bio-Rad Laboratories Major Business
Table 16. Bio-Rad Laboratories Anti-nuclear Antibody (ANA) Testing Product and Solutions
Table 17. Bio-Rad Laboratories Anti-nuclear Antibody (ANA) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Alere Corporate Information, Head Office, and Major Competitors
Table 19. Alere Major Business
Table 20. Alere Anti-nuclear Antibody (ANA) Testing Product and Solutions
Table 21. Alere Anti-nuclear Antibody (ANA) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Erba Diagnostics Corporate Information, Head Office, and Major Competitors
Table 23. Erba Diagnostics Major Business
Table 24. Erba Diagnostics Anti-nuclear Antibody (ANA) Testing Product and Solutions
Table 25. Erba Diagnostics Anti-nuclear Antibody (ANA) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. MBL International Corporate Information, Head Office, and Major Competitors
Table 27. MBL International Major Business
Table 28. MBL International Anti-nuclear Antibody (ANA) Testing Product and Solutions
Table 29. MBL International Anti-nuclear Antibody (ANA) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Merck Corporate Information, Head Office, and Major Competitors
Table 31. Merck Major Business
Table 32. Merck Anti-nuclear Antibody (ANA) Testing Product and Solutions
Table 33. Merck Anti-nuclear Antibody (ANA) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Indur Services Corporate Information, Head Office, and Major Competitors
Table 35. Indur Services Major Business
Table 36. Indur Services Anti-nuclear Antibody (ANA) Testing Product and Solutions
Table 37. Indur Services Anti-nuclear Antibody (ANA) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Trinity Biotech Corporate Information, Head Office, and Major Competitors
Table 39. Trinity Biotech Major Business
Table 40. Trinity Biotech Anti-nuclear Antibody (ANA) Testing Product and Solutions
Table 41. Trinity Biotech Anti-nuclear Antibody (ANA) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 43. Thermo Fisher Scientific Major Business
Table 44. Thermo Fisher Scientific Anti-nuclear Antibody (ANA) Testing Product and Solutions
Table 45. Thermo Fisher Scientific Anti-nuclear Antibody (ANA) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Zeus Scientific Corporate Information, Head Office, and Major Competitors
Table 47. Zeus Scientific Major Business
Table 48. Zeus Scientific Anti-nuclear Antibody (ANA) Testing Product and Solutions
Table 49. Zeus Scientific Anti-nuclear Antibody (ANA) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Global Anti-nuclear Antibody (ANA) Testing Revenue (USD Million) by Players (2019-2021)
Table 51. Global Anti-nuclear Antibody (ANA) Testing Revenue Share by Players (2019-2021)
Table 52. Breakdown of Anti-nuclear Antibody (ANA) Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 53. Anti-nuclear Antibody (ANA) Testing Players Head Office, Products and Services Provided
Table 54. Anti-nuclear Antibody (ANA) Testing Mergers & Acquisitions in the Past Five Years
Table 55. Anti-nuclear Antibody (ANA) Testing New Entrants and Expansion Plans
Table 56. Global Anti-nuclear Antibody (ANA) Testing Revenue (USD Million) by Type (2016-2021)
Table 57. Global Anti-nuclear Antibody (ANA) Testing Revenue Share by Type (2016-2021)
Table 58. Global Anti-nuclear Antibody (ANA) Testing Revenue Forecast by Type (2021-2026)
Table 59. Global Anti-nuclear Antibody (ANA) Testing Revenue by Application (2016-2021)
Table 60. Global Anti-nuclear Antibody (ANA) Testing Revenue Forecast by Application (2021-2026)
Table 61. North America Anti-nuclear Antibody (ANA) Testing Revenue by Type (2016-2021) & (USD Million)
Table 62. North America Anti-nuclear Antibody (ANA) Testing Revenue by Type (2021-2026) & (USD Million)
Table 63. North America Anti-nuclear Antibody (ANA) Testing Revenue by Application (2016-2021) & (USD Million)
Table 64. North America Anti-nuclear Antibody (ANA) Testing Revenue by Application (2021-2026) & (USD Million)
Table 65. North America Anti-nuclear Antibody (ANA) Testing Revenue by Country (2016-2021) & (USD Million)
Table 66. North America Anti-nuclear Antibody (ANA) Testing Revenue by Country (2021-2026) & (USD Million)
Table 67. Europe Anti-nuclear Antibody (ANA) Testing Revenue by Type (2016-2021) & (USD Million)
Table 68. Europe Anti-nuclear Antibody (ANA) Testing Revenue by Type (2021-2026) & (USD Million)
Table 69. Europe Anti-nuclear Antibody (ANA) Testing Revenue by Application (2016-2021) & (USD Million)
Table 70. Europe Anti-nuclear Antibody (ANA) Testing Revenue by Application (2021-2026) & (USD Million)
Table 71. Europe Anti-nuclear Antibody (ANA) Testing Revenue by Country (2016-2021) & (USD Million)
Table 72. Europe Anti-nuclear Antibody (ANA) Testing Revenue by Country (2021-2026) & (USD Million)
Table 73. Asia-Pacific Anti-nuclear Antibody (ANA) Testing Revenue by Type (2016-2021) & (USD Million)
Table 74. Asia-Pacific Anti-nuclear Antibody (ANA) Testing Revenue by Type (2021-2026) & (USD Million)
Table 75. Asia-Pacific Anti-nuclear Antibody (ANA) Testing Revenue by Application (2016-2021) & (USD Million)
Table 76. Asia-Pacific Anti-nuclear Antibody (ANA) Testing Revenue by Application (2021-2026) & (USD Million)
Table 77. Asia-Pacific Anti-nuclear Antibody (ANA) Testing Revenue by Region (2016-2021) & (USD Million)
Table 78. Asia-Pacific Anti-nuclear Antibody (ANA) Testing Revenue by Region (2021-2026) & (USD Million)
Table 79. South America Anti-nuclear Antibody (ANA) Testing Revenue by Type (2016-2021) & (USD Million)
Table 80. South America Anti-nuclear Antibody (ANA) Testing Revenue by Type (2021-2026) & (USD Million)
Table 81. South America Anti-nuclear Antibody (ANA) Testing Revenue by Application (2016-2021) & (USD Million)
Table 82. South America Anti-nuclear Antibody (ANA) Testing Revenue by Application (2021-2026) & (USD Million)
Table 83. South America Anti-nuclear Antibody (ANA) Testing Revenue by Country (2016-2021) & (USD Million)
Table 84. South America Anti-nuclear Antibody (ANA) Testing Revenue by Country (2021-2026) & (USD Million)
Table 85. Middle East & Africa Anti-nuclear Antibody (ANA) Testing Revenue by Type (2016-2021) & (USD Million)
Table 86. Middle East & Africa Anti-nuclear Antibody (ANA) Testing Revenue by Type (2021-2026) & (USD Million)
Table 87. Middle East & Africa Anti-nuclear Antibody (ANA) Testing Revenue by Application (2016-2021) & (USD Million)
Table 88. Middle East & Africa Anti-nuclear Antibody (ANA) Testing Revenue by Application (2021-2026) & (USD Million)
Table 89. Middle East & Africa Anti-nuclear Antibody (ANA) Testing Revenue by Country (2016-2021) & (USD Million)
Table 90. Middle East & Africa Anti-nuclear Antibody (ANA) Testing Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Anti-nuclear Antibody (ANA) Testing Picture
Figure 2. Global Anti-nuclear Antibody (ANA) Testing Revenue Market Share by Type in 2020
Figure 3. Indirect Immunofluorescence
Figure 4. Enzyme-linked Immunosorbent Assay (ELISA)
Figure 5. Other
Figure 6. Anti-nuclear Antibody (ANA) Testing Revenue Market Share by Application in 2020
Figure 7. Hospital Picture
Figure 8. Clinic Picture
Figure 9. Other Picture
Figure 10. Global Anti-nuclear Antibody (ANA) Testing Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Anti-nuclear Antibody (ANA) Testing Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Anti-nuclear Antibody (ANA) Testing Revenue Market Share by Region (2016-2026)
Figure 13. Global Anti-nuclear Antibody (ANA) Testing Revenue Market Share by Region in 2020
Figure 14. North America Anti-nuclear Antibody (ANA) Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Anti-nuclear Antibody (ANA) Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Anti-nuclear Antibody (ANA) Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Anti-nuclear Antibody (ANA) Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Anti-nuclear Antibody (ANA) Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Anti-nuclear Antibody (ANA) Testing Market Drivers
Figure 20. Anti-nuclear Antibody (ANA) Testing Market Restraints
Figure 21. Anti-nuclear Antibody (ANA) Testing Market Trends
Figure 22. Abcam Recent Developments and Future Plans
Figure 23. Antibodies Recent Developments and Future Plans
Figure 24. Bio-Rad Laboratories Recent Developments and Future Plans
Figure 25. Alere Recent Developments and Future Plans
Figure 26. Erba Diagnostics Recent Developments and Future Plans
Figure 27. MBL International Recent Developments and Future Plans
Figure 28. Merck Recent Developments and Future Plans
Figure 29. Indur Services Recent Developments and Future Plans
Figure 30. Trinity Biotech Recent Developments and Future Plans
Figure 31. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 32. Zeus Scientific Recent Developments and Future Plans
Figure 33. Global Anti-nuclear Antibody (ANA) Testing Revenue Share by Players in 2020
Figure 34. Anti-nuclear Antibody (ANA) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 35. Global Top 3 Players Anti-nuclear Antibody (ANA) Testing Revenue Market Share in 2020
Figure 36. Global Top 10 Players Anti-nuclear Antibody (ANA) Testing Revenue Market Share in 2020
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 38. Global Anti-nuclear Antibody (ANA) Testing Revenue Share by Type in 2020
Figure 39. Global Anti-nuclear Antibody (ANA) Testing Market Share Forecast by Type (2021-2026)
Figure 40. Global Anti-nuclear Antibody (ANA) Testing Revenue Share by Application in 2020
Figure 41. Global Anti-nuclear Antibody (ANA) Testing Market Share Forecast by Application (2021-2026)
Figure 42. North America Anti-nuclear Antibody (ANA) Testing Sales Market Share by Type (2016-2026)
Figure 43. North America Anti-nuclear Antibody (ANA) Testing Sales Market Share by Application (2016-2026)
Figure 44. North America Anti-nuclear Antibody (ANA) Testing Revenue Market Share by Country (2016-2026)
Figure 45. United States Anti-nuclear Antibody (ANA) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Anti-nuclear Antibody (ANA) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Anti-nuclear Antibody (ANA) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Anti-nuclear Antibody (ANA) Testing Sales Market Share by Type (2016-2026)
Figure 49. Europe Anti-nuclear Antibody (ANA) Testing Sales Market Share by Application (2016-2026)
Figure 50. Europe Anti-nuclear Antibody (ANA) Testing Revenue Market Share by Country (2016-2026)
Figure 51. Germany Anti-nuclear Antibody (ANA) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Anti-nuclear Antibody (ANA) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Anti-nuclear Antibody (ANA) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Anti-nuclear Antibody (ANA) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Anti-nuclear Antibody (ANA) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Anti-nuclear Antibody (ANA) Testing Sales Market Share by Type (2016-2026)
Figure 57. Asia-Pacific Anti-nuclear Antibody (ANA) Testing Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Anti-nuclear Antibody (ANA) Testing Revenue Market Share by Region (2016-2026)
Figure 59. China Anti-nuclear Antibody (ANA) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Anti-nuclear Antibody (ANA) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South Korea Anti-nuclear Antibody (ANA) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Anti-nuclear Antibody (ANA) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Anti-nuclear Antibody (ANA) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Anti-nuclear Antibody (ANA) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Anti-nuclear Antibody (ANA) Testing Sales Market Share by Type (2016-2026)
Figure 66. South America Anti-nuclear Antibody (ANA) Testing Sales Market Share by Application (2016-2026)
Figure 67. South America Anti-nuclear Antibody (ANA) Testing Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Anti-nuclear Antibody (ANA) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Anti-nuclear Antibody (ANA) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East and Africa Anti-nuclear Antibody (ANA) Testing Sales Market Share by Type (2016-2026)
Figure 71. Middle East and Africa Anti-nuclear Antibody (ANA) Testing Sales Market Share by Application (2016-2026)
Figure 72. Middle East and Africa Anti-nuclear Antibody (ANA) Testing Revenue Market Share by Country (2016-2026)
Figure 73. Turkey Anti-nuclear Antibody (ANA) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Anti-nuclear Antibody (ANA) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. UAE Anti-nuclear Antibody (ANA) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source

---